Table 5.
Meta-regression for each moderator covariate
| Effect size | 95% | CI | P Value | Χ2 | I2 | |
| Publication date (per year) | 0.96 | 0.85, | 1.09 | 0.551 | 0.319 | 12.70 |
| RCT study compared with non-RCT | 0.66 | 0.34, | 1.27 | 0.219 | 0.403 | 3.60 |
| Route compared with lower route | ||||||
| Capsules | 2.48 | 1.01, | 6.06 | 0.047 | 0.531 | 0.10 |
| Upper route | 1.05 | 0.38, | 2.91 | 0.931 | ||
| FMT | 1.15 | 0.97, | 1.37 | 0.115 | 0.489 | 0.20 |
| Antibiotic | 2.02 | 0.92, | 2.00 | 0.037 | 0.655 | 0.20 |
| Mayo score (per point) | 1.05 | 0.57, | 4.95 | 0.159 | 0.431 | 1.30 |
CI, confidence interval; FMT, fecal microbiota transfer; RCT, randomized controlled trials.
Observed effect size and 95% CI, the P value, and the homogeneity parameters (ratio I2 and P value of the χ2 test of homogeneity).